Client News

Abivax SA: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

4basebio AG reports first quarter 2020 financial results

CENTOGENE AG: Blaupause für die Bundesrepublik – CENTOGENE ermöglicht Coronavirus-Tests am Gymnasium Neustrelitz

CENTOGENE Announces Global Expansion of COVID-19 Testing

MagForce AG Publishes Shareholder Letter

Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome

Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020

InflaRx Reports Full Year 2019 Financial & Operating Results

Secarna Pharmaceuticals enters into cooperation with Guangzhou’s Sun Yat-sen University to develop a treatment for SARS-CoV-2 viral infections

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System